期刊文献+

叶酸修饰多柔比星聚合物胶束的制备及体外抗肿瘤活性评价 被引量:4

Preparation and in vitro Anti-tumor Activity Evaluation of Folate-conjugated Polymeric Micelles Loaded with Doxorubicin
原文传递
导出
摘要 合成了叶酸-聚乙二醇-二硬脂酰磷脂酰乙醇胺(Folate-PEG-DSPE),并用其作为靶向肿瘤的功能性材料,以甲氧基聚乙二醇-二硬脂酰磷脂酰乙醇胺(MPEG-DSPE)作为骨架材料,采用成膜水化法制备载多柔比星(1)胶束。所得胶束呈球状结构,粒径为(20±5)nm,叶酸修饰和非叶酸修饰胶束的包封率和载药量分别为(78.8±1.52)%、(79.2±147)%和(1 3.6±1.26)%、(1 3.9±1.19)%。流式细胞结果显示,分别给予游离罗丹明B(Rh B)、叶酸修饰和非叶酸修饰的载RhB胶束,摄取荧光的巨噬细胞分别占细胞总数的36.6%、1.5%和4.4%,说明聚合物胶束可显著减弱巨噬细胞的吞噬作用。体外抗KB人口腔上皮癌细胞活性的试验结果显示,1、叶酸修饰和非叶酸修饰胶束的IC_(50)分别为29 7、0.61和4.12μmol/L,表明叶酸修饰的聚合物胶束能显著提高1的抗肿瘤活性。 The block copolymer,folate-polyethylene glycol-distearoyl phosphatidylethanolamine(Folate-PEG-DSPE) was synthesized.The polymeric micelles loaded with doxorubicin(1) were prepared by the thin-film hydration method with methoxy-polyethylene glycol-distearoyl phosphatidylethanolamine(MPEG-DSPE) as the carrier and Folate-PEG -DSPE as target material.The prepared micelles were uniform and spherical with a mean diameter of(20±5)nm.The encapsulation and drug loading were(78.8±1.52)%and(13.6±1.26)%for folate-conjugated micelles,(79.2±1.47)% and(13.9±1.19)%for folate-unconjugated micelles.The fluorescence rate of rhodamine B(Rh B),folate-conjugated and folate-unconjugated micelles loaded with Rh B detected by flow cytometry were 36.6%,1.5%and 4.4%,which indicated that the micelles could avoid phagocytosis by macrophages.The results of in vitro cytotoxicity test with KB cells showed that the values of IC_(50) of 1,folate-conjugated and folate-unconjugated micelles loaded with 1 were 29.7,0.61 and 4.12μmol/L,which indicated that the anti-tumor activity of 1 could be significantly enhanced with folate-conjugated polymeric micelles as carrier.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2011年第7期512-517,共6页 Chinese Journal of Pharmaceuticals
基金 国家自然科学基金(30772655) 上海市纳米专项(0952nm03300) 国家重大科创项目(2009ZX09310-006)
关键词 叶酸聚合物胶束 多柔比星 体外抗肿瘤活性 folate-conjugated polymeric micelle doxorubicin in vitro anti-tumor activity
  • 相关文献

参考文献8

二级参考文献118

  • 1虞冠华 龙娜.MTT法快速测定TNF活性[J].细胞生物学杂志,1994,16(6):48-48.
  • 2Kikuchi H, Suzuki N, Ebihara K, et al. Gene delivery using liposome technology [ J]. J Control Release, 1999, 62:269 - 277.
  • 3Tseng WC, Huang L. Liposome based gene therapy [ J ]. Res Focus, 1998,1:206 - 213.
  • 4Dass CR, Choong PF. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability [ J ]. J Control Release, 2006,113 : 155 - 163.
  • 5Weitman SD, Weinberg AG, Coney LR, et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis [ J]. Cancer Res, 1992, 52:6708 - 6711.
  • 6Bagnoli M, Canevari S, Figini M, et al. A step further in understanding the biology of the folate receptor in ovarian carcinoma [ J ]. Gynecol Oneol, 2003,88 :S140 - S144.
  • 7Lu Y, Sega E, Leamon CP, et al. Folate receptor- targeted immunotherapy of cancer: mechanism and therapeutic potential [ J ]. Adv Drug Deliv Rev, 2004,56:1161 - 1176.
  • 8Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor [ JJ. Adv Drug Deliv Rev, 2000,41:147 -162.
  • 9Dass CR, Burton MA. Lipoplexes and tumors. A review [J]. J Pharm Pharmacol, 1999,51:755 -770.
  • 10Goormaghtigh E, Chatelain P, Caspers J, et al. Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity[J].Biochem Pharmacol, 1980,29(21) :3 003.

共引文献78

同被引文献35

  • 1许向阳,李玲,周建平.聚合胶束载药多柔比星的研究进展[J].中国新药杂志,2007,16(1):28-32. 被引量:10
  • 2崔福德.药剂学[M].6版.北京:人民卫生出版社,2008:126.
  • 3Poirier V J, Thamm DH, Kurzman ID, et al. Liposome- encapsulated doxorubiein (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats [J]. J Vet Intern Med, 2002, 14 (6): 726 -731.
  • 4Swenson CE, Perkins WR, Robert P, et al. Liposome technology and the development of Myocet vM (liposomal doxorubicin citrate) [J:. The Breast, 2001, 10 (Suppl 2) : 1-7.
  • 5Temming K, Schiffelers RM, Molema G, et al. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature EJ]. Drug Resist Updat, 2005, 8 (6) : 381-402.
  • 6Kibria G, Hatakeyama H, Ohga N, et al. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery [J]. J Controlled Release, 2011,153 (2) : 141-148.
  • 7Yang DB, Zhu JB, Huang Z J, et al. Synthesis and application of poly (ethylene glycol) -cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles [J]. Colloids SurfB Biointerfaces, 2008, 63 (2) : 192-199.
  • 8Jiang X, Sha X, Xin H, et al. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c (RGDyK) peptide for targeted paelitaxel delivery to integrin- rich tumors [J]. Biomaterials, 2011, 32 (35) : 9457-9469.
  • 9Sohn JS, Jin JI, Hess M, et al. Polymerprodrug approaches applied to paclitaxel [J]. Polym Chem, 2010, 1 (6) : 778-792.
  • 10Sarpietro MG, Ottimo S, Paolino D, et al. Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers [J]. Int J Pharm, 2012, 436 (1-2) : 135-140.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部